NCT07538596Not yet recruiting
Medication Training Via Ignite Based on Roy Model in Heart Failure: Medication Adherence and Symptom Management
The Effect of Medication Management Training Delivered Via the Digital Presentation Format Ignite, Based on the Roy Adaptation Model, on Medication Adherence and Symptom Management in Individuals Diagnosed With Heart Failure
Source: ClinicalTrials.gov · Last updated 20 Apr 2026
Brief summary (registry, in English)
The goal of this clinical trial is to learn if a structured medication training program can help people with heart failure better manage their condition. The program is based on the Roy Adaptation Model and is designed to support how people adjust to their illness. The main questions it aims to answer are: Does the training program improve heart failure symptoms? Does the training program help participants take their medications as prescribed? Researchers will compare a training program group to a control group receiving standard care to see if the program is effective. Participants will: Be randomly assigned to either a training program group or a control group Receive the training program through WhatsApp after hospital discharge or receive standard discharge education Be followed for 12 weeks Complete questionnaires at the start of the study, at 4 weeks, and at 12 weeks
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- First submitted
- 7 Jan 2026
- Start date
- 15 Apr 2026
- Primary completion date
- 25 Aug 2026
- Lead sponsor
- Saglik Bilimleri Universitesi
- Diseases
- Heart failure
- NCT number
- NCT07538596
What you commit to
- Study type: Interventional
- Planned participants: 70
- From 15 Apr 2026 to the primary completion date, 25 Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Lab values
- Low ejection fraction (left ventricle EF. 40%)
- Preserved ejection fraction (left ventricular EF.50%)
Age
- Not being willing to participate in the study don't be under the age of 18
Other
- Lack of ability to read, write and speak Turkish
Who the study is looking for
- Must be 18 years of age or older.
- Individuals who are willing to participate in the study
- No communication problems
- Having been diagnosed with KY for at least 6 months
- Having the ability to read, write and speak Turkish .
- Mildly reduced ejection fraction (left ventricular EF 41-49%)
- Individuals with WhatsApp application
- Individuals who can use a smartphone
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Suleyman Yalcin City Hospital Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.